Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001582945-20-000004
Filing Date
2020-01-16
Accepted
2020-01-16 15:29:35
Documents
1
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9127
  Complete submission text file 0001582945-20-000004.txt   10532
Mailing Address 885 ARAPAHOE ROAD BOULDER CO 80302
Business Address 885 ARAPAHOE ROAD BOULDER CO 80302 303-443-4430
TransBiotec, Inc. (Issuer) CIK: 0001425627 (see all company filings)

EIN.: 260731818 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2721 Periodicals: Publishing or Publishing & Printing

Mailing Address 730 15TH STREET BOULDER CO 80302
Business Address
Moore Kevin D (Reporting) CIK: 0001793908 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53316 | Film No.: 20530700